As the number of patients suffering from chronic pain increases, the interventional pain market continues to grow. Physicians and device developers are rising to the challenge by offering more personalized pain treatment options for an expanding list of indications. As a result, new differentiators for spinal cord stimulation (SCS) players have emerged, as well as newcomers in the peripheral nerve stimulation (PNS) market. Beyond neuromodulation, minimally-invasive surgical (MIS) spine procedures, sacroiliac (SI) joint fusion and regenerative medicine products also provide innovative solutions for chronic pain management. In this interesting article, SmartTRAK highlights the newest data, innovation and market developments at the American Society of Pain and Neuroscience (ASPN) 2023 Annual Meeting held in Miami, FL.
Among the many topics discussed in comprehensive detail in this article, which can be downloaded here, are:
- SCS Sees Cutthroat Competition
- MRI Compatibility and Closed-Loop SCS
- Painful Diabetic Neuropathy (PDN)
- Artificial Intelligence, Programming Solutions and Remote Monitoring
- Expanding Horizons in PNS
- Types of Peripheral Nerve Stimulation
- Outcomes, Comfort and Wearability for Externally-powered Devices
- Injectrode Technology
- What’s New in MIS Spine and SI Joint Fusion
- Leveraging Enabling Technology for Pain Procedures
- Innovations in MIS Spine and SI Joint Instrumentation
- Scientific Focus on Biologics and Regenerative Medicine
To identify current and future trends in interventional pain management and PNS, SmartTRAK recently surveyed 30 interventional pain physicians, including 18 who perform PNS, to get an inside view of procedure trends, what treatments and devices they use and who they see as future winners in the chronic pain space. To purchase the results of this comprehensive survey, see SmartTRAK’s Trends in Interventional Pain Management and PNS.